Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 554, Issue 1, Pages 12-17Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejphar.2006.09.072
Keywords
COX-2; diabetes; hyperalgesia
Categories
Ask authors/readers for more resources
Members of the cyclooxygenase (COX) family are known to catalyze the rate-limiting steps of prostaglandins synthesis and reported to be involved in neuropathic pain. Diabetic neuropathy is a type of neuropathic pain, though it is not clear if COX is relevant to the condition. Recently, spinal COX-2 protein was found to be increasing in streptozotocin-induced rats as compared to the constitutive expression. We attempted to determine which cyclooxygenase isoforms are involved in streptozotocin-induced mechanical hyperalgesia, which was induced by a single intraperitoneal injection of 75 mg/kg of streptozotocin. Intrathecal administrations of the COX-2 inhibitors SC-58125 (7-100 mu g) and NS-398 (7-60 mu g), as well as a high dose (100 mu g) of the COX-I inhibitor SC-560 attenuated hyperalgesia, whereas intrathecal administrations of a low dose (10 mu g) of SC-560 and the COX-3 inhibitor acetaminophen (1-7 mg) did not. Further, intrathecal administration of SC-58125 (100 mu g) did not produce an analgesic effect in normal rats. These results indicate that intrathecal administration of COX-2 inhibitors has an anti-hyperalgesic effect on streptozotocin-induced mechanical hyperalgesia and we concluded that spinal COX-2 is pivotal in streptozotocin-induced hyperalgesia. (c) 2006 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available